United States - English - NLM (National Library of Medicine)

rising pharmaceuticals, inc. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 3.5 mg in 1 ml - diclofenac sodium ophthalmic solution is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery. diclofenac sodium ophthalmic solution is contraindicated in patients who are hypersensitive to any component of the medication.

United States - English - NLM (National Library of Medicine)

akorn - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 1 mg in 1 ml - diclofenac sodium ophthalmic solution, 0.1% is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery. diclofenac sodium ophthalmic solution, 0.1% is contraindicated in patients who are hypersensitive to any component of the medication.

United States - English - NLM (National Library of Medicine)

rebel distributors corp - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 1 mg in 1 ml - diclofenac sodium ophthalmic is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery. diclofenac sodium ophthalmic is contraindicated in patients who are hypersensitive to any component of the medication.

United States - English - NLM (National Library of Medicine)

sandoz inc - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 1 mg in 1 ml - diclofenac sodium ophthalmic solution is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery. diclofenac sodium ophthalmic solution is contraindicated in patients who are hypersensitive to any component of the medication.

United States - English - NLM (National Library of Medicine)

bausch & lomb incorporated - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 1 mg in 1 ml - diclofenac sodium ophthalmic solution is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction and for the temporary relief of pain and photophobia in patients undergoing corneal refractive surgery. diclofenac sodium ophthalmic solution is contraindicated in patients who are hypersensitive to any component of the medication.

United States - English - NLM (National Library of Medicine)

falcon pharmaceuticals, ltd. - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - solution - 1 mg in 1 ml - diclofenac sodium ophthalmic solution, 0.1% is indicated for the treatment of postoperative inflammation in patients who have undergone cataract extraction. diclofenac sodium ophthalmic solution, 0.1% is contraindicated in patients who are hypersensitive to any component of the medication.

Australia - English - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: povidone; peg-40 hydrogenated castor oil; maize starch; triethyl citrate; purified talc; methacrylic acid - ethyl acrylate copolymer (1:1); lactose monohydrate; sodium starch glycollate type a; colloidal anhydrous silica; iron oxide yellow; magnesium stearate; hypromellose; titanium dioxide; microcrystalline cellulose - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - English - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; triethyl citrate; povidone; hypromellose; methacrylic acid - ethyl acrylate copolymer (1:1); sodium starch glycollate type a; microcrystalline cellulose; maize starch; iron oxide yellow; magnesium stearate; purified talc; peg-40 hydrogenated castor oil; titanium dioxide - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - English - Department of Health (Therapeutic Goods Administration)

medreich australia pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: colloidal anhydrous silica; peg-40 hydrogenated castor oil; iron oxide yellow; maize starch; titanium dioxide; triethyl citrate; sodium starch glycollate type a; methacrylic acid - ethyl acrylate copolymer (1:1); magnesium stearate; hypromellose; lactose monohydrate; povidone; purified talc; microcrystalline cellulose - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.

Australia - English - Department of Health (Therapeutic Goods Administration)

gm pharma international pty ltd - diclofenac sodium, quantity: 25 mg - tablet, enteric coated - excipient ingredients: methacrylic acid - ethyl acrylate copolymer (1:1); maize starch; sodium starch glycollate type a; lactose monohydrate; triethyl citrate; purified talc; microcrystalline cellulose; iron oxide yellow; titanium dioxide; colloidal anhydrous silica; peg-40 hydrogenated castor oil; povidone; hypromellose; magnesium stearate - inflammatory and degenerative forms of rheumatism: rheumatoid arthritis and osteoarthritis. relief of acute or chronic pain states in which there is an,inflammatory component. symptomatic treatment of primary dysmenorrhoea.